makattack you might not expect POH needs to raise more than $7m...

makattack you might not expect POH needs to raise more than $7m but Southern Cross does, they estimate POH needs approx $18m so your 10% dilution looks more like 25% at current prices, if you think that's immaterial then we have a different point of view on dilution.

SCE also has a price target of 40c to 80c (and that excludes AOD). You can't just look at the dilution and not take into account the benefits of the injection. SCEs price target in MAY included dilution of $15m capital injection. If POH needs to raise $18mill its because they are going to commercialise on their own without up-front fees. POH will partner though, I have no doubt of that. Best to have global marketing experts doing what they do best. Either way the investment is predominantly for the purposes of commercialisation, not research. A very distinct difference.

As I said, this dilution placement talk is just scare tactics on the part of a couple of posters. For what reason I am unsure. If a placement is required I dont believe it will be anywhere near the current shareprice. Many announcements coming our way will attract attention again.

Of course my opinions is only 1.